![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/28/2906002/0/en/Tiziana-Receives-3-4-Million-in-Non-Dilutive-Funding.html
https://www.globenewswire.com/news-release/2024/06/26/2904379/0/en/Tiziana-Life-Sciences-to-Dose-First-Patient-with-Moderate-Alzheimer-s-Disease-with-Foralumab.html
https://www.globenewswire.com/news-release/2024/06/11/2896746/0/en/FDA-Accepts-Tiziana-Life-Sciences-Fast-Track-Designation-Submission-for-Treatment-of-Multiple-Sclerosis.html
https://www.globenewswire.com/news-release/2024/06/06/2894698/0/en/Tiziana-Life-Sciences-Announces-Six-Month-Qualitative-Improvement-in-Neuroimaging-in-80-of-Multiple-Sclerosis-Patients-Receiving-Intranasal-Foralumab.html
https://www.globenewswire.com/news-release/2024/06/04/2893117/0/en/Tiziana-Life-Sciences-Submits-Grant-Application-to-ALS-Association-to-Fund-Clinical-Trial-of-Intranasal-Foralumab.html
https://www.globenewswire.com/news-release/2024/05/30/2890604/0/en/Tiziana-Life-Sciences-Scientific-Board-Chairman-to-Receive-Prestigious-Award-for-Multiple-Sclerosis-Research.html
https://www.globenewswire.com/news-release/2024/05/13/2880286/0/en/Tiziana-Life-Sciences-Files-for-Orphan-Drug-Designation-for-Intranasal-Foralumab.html
https://www.globenewswire.com/news-release/2024/04/25/2869777/0/en/Tiziana-Life-Sciences-Reports-Positive-3-Month-Neuroimaging-Scores-in-Multiple-Sclerosis-Patients-Receiving-Intranasal-Foralumab.html
https://www.globenewswire.com/news-release/2024/04/23/2867512/0/en/Tiziana-Life-Sciences-Announces-FDA-Allowance-for-Additional-Twenty-Patients-to-be-Enrolled-in-the-Intranasal-Foralumab-Multiple-Sclerosis-Expanded-Access-Program.html
https://www.globenewswire.com/news-release/2024/04/22/2866733/0/en/Tiziana-Life-Sciences-Announces-Additional-Clinical-Improvements-Among-Multiple-Sclerosis-Patients-in-its-Expanded-Access-Program.html